577 related articles for article (PubMed ID: 18683104)
1. Oncolytic vaccinia virus: from bedside to benchtop and back.
Thorne SH
Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
[TBL] [Abstract][Full Text] [Related]
2. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
3. Next-generation oncolytic vaccinia vectors.
Thorne SH
Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
[TBL] [Abstract][Full Text] [Related]
4. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus and oncolytic virotherapy of cancer.
Thorne SH; Hwang TH; Kirn DH
Curr Opin Mol Ther; 2005 Aug; 7(4):359-65. PubMed ID: 16121702
[TBL] [Abstract][Full Text] [Related]
6. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
7. Advances in oncolytic viral therapy.
Woo Y; Adusumilli PS; Fong Y
Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of oncolytic measles virus: promises and challenges.
Galanis E
Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
[TBL] [Abstract][Full Text] [Related]
9. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
10. Naturally oncolytic viruses.
Roberts MS; Lorence RM; Groene WS; Bamat MK
Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
[TBL] [Abstract][Full Text] [Related]
11. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
Liu TC; Kirn D
Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
[TBL] [Abstract][Full Text] [Related]
12. Reovirus - possible therapy of cancer.
Figova K; Hrabeta J; Eckschlager T
Neoplasma; 2006; 53(6):457-62. PubMed ID: 17167712
[TBL] [Abstract][Full Text] [Related]
13. JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
Merrick AE; Ilett EJ; Melcher AA
Curr Opin Investig Drugs; 2009 Dec; 10(12):1372-82. PubMed ID: 19943208
[TBL] [Abstract][Full Text] [Related]
14. A demand for next-generation oncolytic adenoviruses.
Hermiston T
Curr Opin Mol Ther; 2006 Aug; 8(4):322-30. PubMed ID: 16955695
[TBL] [Abstract][Full Text] [Related]
15. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
Kapadia R; Coffey MC
Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic virus therapy for prostate cancer.
Fukuhara H; Homma Y; Todo T
Int J Urol; 2010 Jan; 17(1):20-30. PubMed ID: 19832925
[TBL] [Abstract][Full Text] [Related]
17. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
Bitzer M; Lauer UM
Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1.
Huang B; Sikorski R; Kirn DH; Thorne SH
Gene Ther; 2011 Feb; 18(2):164-72. PubMed ID: 20739958
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic vaccinia virus for the treatment of cancer.
Guse K; Cerullo V; Hemminki A
Expert Opin Biol Ther; 2011 May; 11(5):595-608. PubMed ID: 21338330
[TBL] [Abstract][Full Text] [Related]
20. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
